Antibody-mediated neutralization of HMGB1 or antagonism of its receptor (receptor for advanced glycation end products, RAGE) markedly reduced the infarct size in a mouse ischemia/reperfusion model middle cerebral artery occlusion (MCAO; Muhammad et al., 2008). This evidence concerns the gene AGER and ischemia.